NFKB1 and dilated cardiomyopathy: This pathway is also one of the main inducers of the NF-κB pathway that is activated after inflammatory stimulus, ischemia/reperfusion, in congestive heart failure, dilated cardiomyopathy, after ischemic and pharmacological preconditioning, and in hypertrophy of isolated cardiomyocytes (76).